Lysyl Oxidase Pharmacological Inhibition of Bone Marow Fibrosis03/01/2016 - 12/31/2022 (PI)
Pharmaxis
A path to thrombosis in primary myelofibrosis12/24/2017 - 11/30/2021 (PI)
NIH/National Heart, Lung, and Blood Institute5R01HL136363-03
Training Program in Cardiovascular Biology: Pre-Doctoral12/01/2014 - 11/30/2020 (PI)
NIH/National Heart, Lung, and Blood Institute5T32HL007969-15
Mechanism of Bone Marrow Neoplasm-Induced Osteosclerosis05/01/2018 - 04/30/2020 (Multi-PI)
PI:
Katya Ravid, DScNIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases5R21AR072748-02
Mechanisms Regulating Megakaryocyte Development04/01/2012 - 09/30/2017 (PI)
NIH/National Heart, Lung, and Blood Institute5R01HL080442-09
Nanoplatforms for Imaging Bone Marrow Fibrosis10/01/2014 - 09/30/2016 (PI)
MPN Research Foundation
Mechanisms Regulating Megakaryocte Development04/01/2012 - 03/31/2016 (PI)
NIH/National Heart, Lung, and Blood Institute2R01HL080442-06A1
Training in Cardiovascular Biology: Predoctoral07/01/2001 - 11/30/2014 (PI)
NIH/National Heart, Lung, and Blood Institute5T32HL007969-10
Training in Cardiovascular Biology: Predoctoral07/01/2011 - 06/30/2014 (PI)
NIH/National Heart, Lung, and Blood Institute5T32HL007969-09
Adenosine Receptors and Atherogenesis04/01/2009 - 03/31/2014 (PI)
NIH/National Heart, Lung, and Blood Institute5R01HL093149-04
Showing 10 of 14 results.
Show All Results
The A2b Adenosine Receptor as Regulator of Type II Diabetes09/30/1997 - 03/31/2013 (Subcontract PI)
Boston Medical Center Corporation NIH NIDDK5P30DK046200-20
Properties of Polypoloid Cells in a Model of Aging06/01/2003 - 05/31/2005 (PI)
NIH/National Institute on Aging1 R03 AG22623 01
Mechanisms Regulating Endomitosis in Megakaryocytes08/01/1997 - 07/31/2004 (PI)
NIH/National Heart, Lung, and Blood Institute5 R01 HL58547 05
Targeting Gene Products to Megakaryocytes/Platelets in Transgenic Mice07/01/1995 - 06/30/2000 (PI)
American Heart Association